|Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection|
RB Fulton, DK Meyerholz, SM Varga
The Journal of Immunology 185 (4), 2382-2392, 2010
|The TCR's sensitivity to self peptide–MHC dictates the ability of naive CD8+ T cells to respond to foreign antigens|
RB Fulton, SE Hamilton, Y Xing, JA Best, AW Goldrath, KA Hogquist, ...
Nature immunology 16 (1), 107-117, 2015
|Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection|
KA Weiss, AF Christiaansen, RB Fulton, DK Meyerholz, SM Varga
The Journal of Immunology 187 (6), 3145-3154, 2011
|Regulation of cytokine production by virus-specific CD8 T cells in the lungs|
RB Fulton, MR Olson, SM Varga
Journal of virology 82 (16), 7799-7811, 2008
|Effects of aging on the adaptive immune response to respiratory virus infections|
RB Fulton, SM Varga
Aging health 5 (6), 775-787, 2009
|Aged mice exhibit a severely diminished CD8 T cell response following respiratory syncytial virus infection|
RB Fulton, KA Weiss, LL Pewe, JT Harty, SM Varga
Journal of virology 87 (23), 12694-12700, 2013
|T cell epitope specificity and pathogenesis of mouse hepatitis virus-1–induced disease in susceptible and resistant hosts|
A Khanolkar, RB Fulton, LL Epping, NL Pham, D Tifrea, SM Varga, ...
The Journal of Immunology 185 (2), 1132-1141, 2010
|McDade RL, Smith PL, Kienker LJ, and Kettman JR Jr|
Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 43, 1749 …, 1997
|Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity|
EM Tam, RB Fulton, JF Sampson, M Muda, A Camblin, J Richards, ...
Science Translational Medicine 11 (512), eaax0720, 2019
|31st annual meeting and associated programs of the Society for Immunotherapy of cancer (SITC 2016): late breaking abstracts|
S Althammer, K Steele, M Rebelatto, TH Tan, T Wiestler, G Schmidt, ...
Journal for ImmunoTherapy of Cancer 4 (2), 223-242, 2016
|Combination writing board/reflecting screen sheet|
K Tatsuki, H Takamoto, K Seki
US Patent 7,303,806, 2007
|Imprime PGG triggers PD-L1 expression on tumor and myeloid cells and prevents tumor establishment in combination with αPD-L1 treatment in vivo|
K Fraser, A Chan, R Fulton, S Leonardo, A Jonas, X Qiu, N Ottoson, ...
Cancer Research 76 (14 Supplement), 2335-2335, 2016
|Abstract LB-087: Imprime PGG drives adaptive immune resistance within the tumor microenvironment by modulating the myeloid compartment and enhances the efficacy of anti-PD1 …|
ALB Jonas, ASH Chan, NR Ottoson, X Qiu, K Fraser, TO Kangas, R Fulton, ...
Cancer Research 76 (14 Supplement), LB-087-LB-087, 2016
|Abstract B019: Imprime PGG, a soluble β-glucan, binds to and activates dendritic cells resulting in enhanced T cell priming, expansion, and cytokine production|
RB Fulton, SM Leonardo, KS Michel, ME Danielson, KB Gorden, JR Graff
Cancer Immunology Research 4 (1 Supplement), B019-B019, 2016
|Imprime PGG decreases regulatory T cell suppression and enhances T cell proliferation and differentiation revealing additional mechanisms for its anti-tumor activity|
SM Leonardo, K Gorden, R Fulton, L Wurst
Cancer Research 75 (15 Supplement), 5034-5034, 2015
|Immune pharmacodynamic responses of the novel cancer immunotherapeutic Imprime PGG in healthy volunteers|
N Bose, NR Ottoson, X Qiu, B Harrison, JR Lowe, MT Uhlik, BT Rathmann, ...
The Journal of Immunology 202 (10), 2945-2956, 2019
|Abstract A160: Imprime PGG binds to neutrophils through complement, Fc, and dectin-1 receptors, priming these cells for enhanced ROS production and tumor cell cytotoxicity|
SM Leonardo, RB Fulton, LR Wurst, KB Gorden, AB Jonas, X Qui, ...
Cancer Immunology Research 4 (1 Supplement), A160-A160, 2016
|Preclinical toxicology and pharmacokinetics of intravenous lipid emulsion fenretinide|
X Liu, B Maurer, T Frgala, J Page, P Noker, R Fulton, M Ames, J Reid, ...
Molecular Cancer Therapeutics 6 (11 Supplement), C159-C159, 2007
|Innate immune modulation: The novel immunotherapeutic Imprime PGG triggers the anti-cancer immunity cycle in concert with tumor-targeting, anti-angiogenic and checkpoint …|
N Bose, K Gorden, A Chan, AJ Bykowski, N Ottoson, D Walsh, X Qiu, ...
CANCER IMMUNOLOGY RESEARCH 5 (3), 2017
|31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one|
A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ...
Journal for ImmunoTherapy of Cancer 4 (1), 1-106, 2016